| RS188493184 |
RPE65
|
Health Risk |
Conflicting classifications of pathogenicity |
Leber congenital amaurosis 2, Retinitis pigmentosa 20 |
| RS1884932883 |
MVK
|
Health Risk |
Likely pathogenic |
Porokeratosis 3, disseminated superficial actinic type |
| RS1884934797 |
SOS2
|
Health Risk |
Conflicting classifications of pathogenicity |
Noonan syndrome 9, Cardiovascular phenotype |
| RS188494894 |
CDKN1C
|
Health Risk |
Conflicting classifications of pathogenicity |
Beckwith-Wiedemann syndrome, IMAGe syndrome |
| RS188498736 |
CDH23
|
Health Risk |
Conflicting classifications of pathogenicity |
Usher syndrome type 1D, Autosomal recessive nonsyndromic hearing loss 12 |
| RS1885086608 |
IRF2BPL
|
Health Risk |
Likely pathogenic |
Neurodevelopmental disorder with regression, abnormal movements |
| RS188508745 |
COL6A2
|
Health Risk |
Conflicting classifications of pathogenicity |
Bethlem myopathy 1A, Bethlem myopathy 1A |
| RS1885090034 |
IRF2BPL
|
Health Risk |
Pathogenic |
— |
| RS1885090126 |
ATXN2
|
Health Risk |
Pathogenic; risk factor |
Spinocerebellar ataxia type 2, Parkinson disease |
| RS1885090179 |
IRF2BPL
|
Health Risk |
Likely pathogenic |
Neurodevelopmental disorder with regression, abnormal movements |
| RS1885090260 |
IRF2BPL
|
Health Risk |
Pathogenic |
Neurodevelopmental disorder with regression, abnormal movements |
| RS1885092046 |
IRF2BPL
|
Health Risk |
Pathogenic |
Neurodevelopmental disorder with regression, abnormal movements |
| RS1885106828 |
IRF2BPL
|
Health Risk |
Pathogenic |
Neurodevelopmental disorder with regression, abnormal movements |
| RS188511209 |
MMP13
|
Health Risk |
Conflicting classifications of pathogenicity |
Metaphyseal anadysplasia, Spondyloepimetaphyseal dysplasia |
| RS1885117995 |
B4GALNT1
|
Health Risk |
Pathogenic/Likely pathogenic |
Spastic paraplegia, Hereditary spastic paraplegia 26 |
| RS1885129547 |
MVK
|
Health Risk |
Conflicting classifications of pathogenicity |
Porokeratosis 3, disseminated superficial actinic type |
| RS1885132066 |
GALC
|
Health Risk |
Pathogenic/Likely pathogenic |
Galactosylceramide beta-galactosidase deficiency, Galactosylceramide beta-galactosidase deficiency |
| RS1885132124 |
IRF2BPL
|
Health Risk |
Likely pathogenic |
Neurodevelopmental disorder with regression, abnormal movements |
| RS1885138493 |
GALC
|
Health Risk |
Pathogenic |
Galactosylceramide beta-galactosidase deficiency, Galactosylceramide beta-galactosidase deficiency |
| RS1885159527 |
IRF2BPL
|
Health Risk |
Likely pathogenic |
— |
| RS188516326 |
DSP
|
Health Risk |
Conflicting classifications of pathogenicity |
Woolly hair-skin fragility syndrome, Lethal acantholytic epidermolysis bullosa |
| RS1885174753 |
IRF2BPL
|
Health Risk |
Pathogenic/Likely pathogenic |
Neurodevelopmental disorder with regression, abnormal movements |
| RS188517529 |
LOXHD1
|
Health Risk |
Conflicting classifications of pathogenicity |
Inborn genetic diseases, Inborn genetic diseases |
| RS1885182398 |
IRF2BPL;LOC107984638
|
Health Risk |
Pathogenic |
— |
| RS1885185522 |
IRF2BPL
|
Health Risk |
Pathogenic |
Neurodevelopmental disorder with regression, abnormal movements |
| RS1885186332 |
RPGRIP1
|
Health Risk |
Pathogenic |
Leber congenital amaurosis 6, Leber congenital amaurosis 6 |
| RS1885190050 |
IRF2BPL
|
Health Risk |
Likely pathogenic |
Neurodevelopmental disorder with regression, abnormal movements |
| RS1885194108 |
RPGRIP1
|
Health Risk |
Pathogenic |
Cone-rod dystrophy 13, Leber congenital amaurosis 6 |
| RS1885229622 |
GALC
|
Health Risk |
Pathogenic |
Galactosylceramide beta-galactosidase deficiency, Galactosylceramide beta-galactosidase deficiency |
| RS1885230326 |
GALC
|
Health Risk |
Pathogenic |
Galactosylceramide beta-galactosidase deficiency, Galactosylceramide beta-galactosidase deficiency |
| RS188523700 |
HMGCS2
|
Health Risk |
Conflicting classifications of pathogenicity |
3-hydroxy-3-methylglutaryl-CoA synthase deficiency, HMGCS2-related disorder |
| RS1885265714 |
GALC
|
Health Risk |
Likely pathogenic |
Galactosylceramide beta-galactosidase deficiency, Galactosylceramide beta-galactosidase deficiency |
| RS1885266215 |
GALC
|
Health Risk |
Pathogenic/Likely pathogenic |
Galactosylceramide beta-galactosidase deficiency, Galactosylceramide beta-galactosidase deficiency |
| RS1885268471 |
GALC
|
Health Risk |
Likely pathogenic |
Galactosylceramide beta-galactosidase deficiency, Galactosylceramide beta-galactosidase deficiency |
| RS1885269233 |
GALC
|
Health Risk |
Pathogenic |
Galactosylceramide beta-galactosidase deficiency, Galactosylceramide beta-galactosidase deficiency |
| RS188527711 |
OTOG
|
Health Risk |
Conflicting classifications of pathogenicity |
Autosomal recessive nonsyndromic hearing loss 18B, Autosomal recessive nonsyndromic hearing loss 18B |
| RS188528174 |
LOXHD1
|
Health Risk |
Conflicting classifications of pathogenicity |
Autosomal recessive nonsyndromic hearing loss 77, LOXHD1-related disorder |
| RS188529539 |
SLC46A1
|
Health Risk |
Conflicting classifications of pathogenicity |
Congenital defect of folate absorption, SLC46A1-related disorder |
| RS1885297366 |
DCT
|
Health Risk |
Pathogenic/Likely pathogenic |
Albinism, Oculocutaneous albinism type 8 |
| RS1885298359 |
DCT
|
Health Risk |
Pathogenic |
Oculocutaneous albinism type 8, Oculocutaneous albinism type 8 |
| RS188531567 |
SHANK3
|
Health Risk |
Conflicting classifications of pathogenicity |
Inborn genetic diseases, Inborn genetic diseases |
| RS188532608 |
SLC19A3
|
Health Risk |
Conflicting classifications of pathogenicity |
Biotin-responsive basal ganglia disease, Biotin-responsive basal ganglia disease |
| RS1885329722 |
TOGARAM1
|
Health Risk |
Pathogenic |
Joubert syndrome, Joubert syndrome 37 |
| RS188533495 |
KCNJ2
|
Health Risk |
Conflicting classifications of pathogenicity |
Andersen Tawil syndrome, Short QT syndrome type 3 |
| RS188534354 |
NRG2
|
Health Risk |
Conflicting classifications of pathogenicity |
Thymoma, Gastric cancer |
| RS1885381246 |
CFL2
|
Health Risk |
Conflicting classifications of pathogenicity |
Nemaline myopathy 7, Centronuclear myopathy |
| RS1885387438 |
CFL2
|
Health Risk |
Pathogenic |
Nemaline myopathy 7, CFL2-related disorder |
| RS1885418521 |
MVK
|
Health Risk |
Pathogenic |
MVK-related disorder, Mevalonic aciduria |
| RS1885455089 |
TMEM260
|
Health Risk |
Pathogenic |
Structural heart defects and renal anomalies syndrome, Structural heart defects and renal anomalies syndrome |
| RS188546474 |
CDH2
|
Health Risk |
Conflicting classifications of pathogenicity |
Inborn genetic diseases, Arrhythmogenic right ventricular cardiomyopathy |
| RS1885473805 |
FANCM
|
Health Risk |
Likely pathogenic |
FANCM-related disorder, FANCM-related disorder |
| RS1885485132 |
FANCM
|
Health Risk |
Conflicting classifications of pathogenicity |
Fanconi anemia, Inborn genetic diseases |
| RS188548539 |
GCDH
|
Health Risk |
Conflicting classifications of pathogenicity |
Glutaric aciduria, type 1 |
| RS1885502120 |
FANCM
|
Health Risk |
Conflicting classifications of pathogenicity |
Fanconi anemia, Inborn genetic diseases |
| RS1885517210 |
FANCM
|
Health Risk |
Conflicting classifications of pathogenicity |
Fanconi anemia, Inborn genetic diseases |
| RS1885521004 |
FANCM
|
Health Risk |
Pathogenic |
Fanconi anemia, FANCM-related disorder |
| RS188555552 |
DIP2C
|
Health Risk |
Conflicting classifications of pathogenicity |
Inborn genetic diseases, Inborn genetic diseases |
| RS188558398 |
ITPR1
|
Health Risk |
Conflicting classifications of pathogenicity |
Autosomal dominant cerebellar ataxia, Intellectual disability |
| RS188563959 |
CDH23
|
Health Risk |
Conflicting classifications of pathogenicity |
Usher syndrome type 1D, Autosomal recessive nonsyndromic hearing loss 12 |
| RS188565648 |
CUL7
|
Health Risk |
Conflicting classifications of pathogenicity |
— |
| RS188566209 |
ADAMTS2
|
Health Risk |
Conflicting classifications of pathogenicity |
Ehlers-Danlos syndrome, dermatosparaxis type |
| RS1885664895 |
MVK
|
Health Risk |
Pathogenic |
Mevalonic aciduria, Hyperimmunoglobulin D with periodic fever |
| RS1885666876 |
MVK
|
Health Risk |
Likely pathogenic |
Porokeratosis 3, disseminated superficial actinic type |
| RS1885671620 |
MVK
|
Health Risk |
Likely pathogenic |
— |
| RS188568413 |
MYO6
|
Health Risk |
Conflicting classifications of pathogenicity |
Autosomal recessive nonsyndromic hearing loss 37, Autosomal dominant nonsyndromic hearing loss 22 |
| RS188569082 |
AP5Z1
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary spastic paraplegia 48, AP5Z1-related disorder |
| RS188572864 |
KASH5
|
Health Risk |
Pathogenic |
Azoospermia, Azoospermia |
| RS1885757549 |
RPGRIP1
|
Health Risk |
Pathogenic |
Leber congenital amaurosis 6, Cone-rod dystrophy 13 |
| RS1885763952 |
RPGRIP1
|
Health Risk |
Likely pathogenic |
Leber congenital amaurosis 6, Leber congenital amaurosis 6 |
| RS1885777585 |
SOS2
|
Health Risk |
Likely pathogenic |
Noonan syndrome 9, Noonan syndrome 9 |
| RS188579132 |
CDKN1B
|
Health Risk |
Conflicting classifications of pathogenicity |
Multiple endocrine neoplasia type 4, Hereditary cancer-predisposing syndrome |
| RS188580757 |
SPTA1
|
Health Risk |
Conflicting classifications of pathogenicity |
— |
| RS188582283 |
ROBO2
|
Health Risk |
Conflicting classifications of pathogenicity |
Vesicoureteral reflux 2, Congenital anomaly of kidney and urinary tract |
| RS188583221 |
AHI1
|
Health Risk |
Conflicting classifications of pathogenicity |
Joubert syndrome, Joubert syndrome 3 |
| RS1885847871 |
FANCM
|
Health Risk |
Likely pathogenic |
Fanconi anemia, Fanconi anemia |
| RS1885850135 |
FANCM
|
Health Risk |
Pathogenic |
Fanconi anemia, Fanconi anemia |
| RS188588568 |
KCNJ2
|
Health Risk |
Conflicting classifications of pathogenicity |
Short QT syndrome type 3, Andersen Tawil syndrome |
| RS1885895082 |
GALC
|
Health Risk |
Pathogenic |
— |
| RS1885915172 |
FUT8
|
Health Risk |
Likely pathogenic |
Congenital disorder of glycosylation with defective fucosylation 1, Congenital disorder of glycosylation with defective fucosylation 1 |
| RS188592517 |
APOB
|
Health Risk |
Conflicting classifications of pathogenicity |
Hypercholesterolemia, autosomal dominant |
| RS188598190 |
PSEN2
|
Health Risk |
Conflicting classifications of pathogenicity |
Alzheimer disease 4, PSEN2-related disorder |
| RS188599299 |
TGFBR2
|
Health Risk |
Conflicting classifications of pathogenicity |
Loeys-Dietz syndrome 2, Loeys-Dietz syndrome 2 |
| RS188600194 |
FGD4
|
Health Risk |
Conflicting classifications of pathogenicity |
Charcot-Marie-Tooth disease type 4H, Charcot-Marie-Tooth disease type 4H |
| RS1886008578 |
GALC
|
Health Risk |
Pathogenic |
— |
| RS1886017689 |
NAXD
|
Health Risk |
Pathogenic |
NAD(P)HX dehydratase deficiency, NAD(P)HX dehydratase deficiency |
| RS188609046 |
MYO15A
|
Health Risk |
Conflicting classifications of pathogenicity |
MYO15A-related disorder, Inborn genetic diseases |
| RS1886145312 |
GALC
|
Health Risk |
Pathogenic/Likely pathogenic |
Galactosylceramide beta-galactosidase deficiency, Fabry disease |
| RS1886145706 |
GALC
|
Health Risk |
Likely pathogenic |
Galactosylceramide beta-galactosidase deficiency, Galactosylceramide beta-galactosidase deficiency |
| RS1886148366 |
GALC
|
Health Risk |
Likely pathogenic |
Galactosylceramide beta-galactosidase deficiency, Galactosylceramide beta-galactosidase deficiency |
| RS188615176 |
DNAH11
|
Health Risk |
Conflicting classifications of pathogenicity |
Primary ciliary dyskinesia, Primary ciliary dyskinesia 7 |
| RS1886161029 |
ATRX
|
Health Risk |
Conflicting classifications of pathogenicity |
Alpha thalassemia-X-linked intellectual disability syndrome, Alpha thalassemia-X-linked intellectual disability syndrome |
| RS188624478 |
EFEMP2
|
Health Risk |
Conflicting classifications of pathogenicity |
Cutis laxa, autosomal recessive |
| RS188625872 |
LMNA
|
Health Risk |
Conflicting classifications of pathogenicity |
Lipoatrophy with Diabetes, Hepatic Steatosis |
| RS188634770 |
DSC2
|
Health Risk |
Conflicting classifications of pathogenicity |
Arrhythmogenic right ventricular dysplasia 11, Cardiomyopathy |
| RS1886394733 |
BCL11B
|
Health Risk |
Likely pathogenic |
Intellectual developmental disorder with speech delay, dysmorphic facies |
| RS1886396455 |
BCL11B
|
Health Risk |
Pathogenic |
Intellectual developmental disorder with speech delay, dysmorphic facies |
| RS1886399419 |
BCL11B
|
Health Risk |
Pathogenic |
— |
| RS188642162 |
IQCE
|
Health Risk |
Conflicting classifications of pathogenicity |
— |
| RS1886427331 |
BCL11B
|
Health Risk |
Pathogenic/Likely pathogenic |
Inborn genetic diseases, Intellectual developmental disorder with speech delay |
| RS1886430140 |
BCL11B
|
Health Risk |
Conflicting classifications of pathogenicity |
— |